RxDoctor Payments Data

Olivia Schapker

Family · Nashville, TNNPI 1265175970

Payments from drug & device makers

$2,944in general payments, 2019–2025

Across 154 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$570
  • Novo Nordisk$536
  • Lilly USA, LLC$368
  • Pfizer$284
  • Amgen$232
  • Exact Sciences$204
  • plus $751 from 11 others

What the payments were for

  • Food & beverage$2,944100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,944 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$6,925
Medicare patients
41
Services billed
528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide37$40,989
XareltoRivaroxaban16$18,919
Ezetimibe30$1,015
Atorvastatin Calcium98$992
Trazodone Hcl45$780
Rosuvastatin Calcium44$780
Losartan Potassium58$725
Fluticasone Propionate34$626
Dicyclomine Hcl11$568
Bupropion XlBupropion Hcl14$561
Gabapentin23$504
Albuterol Sulfate HfaAlbuterol Sulfate11$442
Pravastatin Sodium12$436
Lisinopril53$391
Irbesartan14$372

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$368$40,98937 claims
Johnson & JohnsonXarelto$69$18,91916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →